Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., et al. (1996) · Science · doi:10.1126/science.274.5286.373 · Cited by 1,760
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M. A., Glorioso, J. C., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,342
Danger signals: SOS to the immune system
Gallucci, S., & Matzinger, P. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00191-6 · Cited by 1,204
Xiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 912
Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3227-3234.1996 · Cited by 761
Immune responses to adenovirus and adeno-associated virus in humans
Chirmule, N., Propert, K. J., Magosin, S. A., Qian, Y., Qian, R., & Wilson, J. M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300994 · Cited by 684
Self-citationRecombinant adeno-associated virus for muscle directed gene therapy
Fisher, K. J., Jooss, K., Alston, J., Yang, Y., Haecker, S. E., High, K., Pathak, R., Raper, S. E., & Wilson, J. M. (1997) · Nature Medicine · doi:10.1038/nm0397-306 · Cited by 654
Self-citationTripathy, S. K., Black, H. B., Goldwasser, E., & Leiden, J. M. (1996) · Nature Medicine · doi:10.1038/nm0596-545 · Cited by 628
Kessler, P. D., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P. C., Matelis, L. A., Kurtzman, G. J., & Byrne, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14082 · Cited by 614
Rodríguez, R., Schuur, E. R., Lim, H. Y., Henderson, G. A., Simons, J. W., & Henderson, D. (1997) · PubMed · Cited by 584
Herzog, R. W., Yang, E. Y., Couto, L. B., Hagstrom, J. N., Elwell, D., Fields, P. A., Burton, M., Bellinger, D. A., Read, M. S., Brinkhous, K. M., et al. (1999) · Nature Medicine · doi:10.1038/4743 · Cited by 554
Gene therapy: trials and tribulations
Somia, N., & Verma, I. M. (2000) · Nature Reviews Genetics · doi:10.1038/35038533 · Cited by 554
Sallusto, F., & Lanzavecchia, A. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17717.x · Cited by 523
New perspectives of C1328-137-mediated T cell costimulation
Bluestone, J. A. (1995) · Immunity · doi:10.1016/1074-7613(95)90000-4 · Cited by 513
Kirn, D., Martuza, R. L., & Zwiebel, J. (2001) · Nature Medicine · doi:10.1038/89901 · Cited by 502
Jooss, K., Yang, Y., Fisher, K. J., & Wilson, J. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4212-4223.1998 · Cited by 470
Self-citationSnyder, R. O., Miao, C., Meuse, L., Tubb, J., Donahue, B. A., Lin, H.-F., Stafford, D. W., Patel, S., Thompson, A. R., Nichols, T., et al. (1999) · Nature Medicine · doi:10.1038/4751 · Cited by 409
O'Riordan, C. R., Lachapelle, A., Delgado, C., Parkes, V., Wadsworth, S. C., Smith, A. E., & Francis, G. E. (1999) · Human Gene Therapy · doi:10.1089/10430349950018021 · Cited by 409
Morral, N., O’Neal, W., Rice, K., Leland, M., Kaplan, J., Piedra, P. A., Zhou, H., Parks, R. J., Velji, R., Aguilar-Córdova, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12816 · Cited by 409
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors
Zaiss, A.-K., Liu, Q., Bowen, G. P., Wong, N. C. W., Bartlett, J. S., & Muruve, D. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4580-4590.2002 · Cited by 394
Zhang, Y., Chirmule, N., Gao, G.-P., Qian, R., Croyle, M., Joshi, B., Tazelaar, J., & Wilson, J. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0329 · Cited by 376
Self-citationMorsy, M. A., Gu, M., Motzel, S., Zhao, J., Lin, J., Su, Q., Allen, H., Franlin, L., Parks, R. J., Graham, F. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7866 · Cited by 365
Raper, S. E., Yudkoff, M., Chirmule, N., Gao, G.-P., Nunes, F., Haskal, Z. J., Furth, E. E., Propert, K. J., Robinson, M. B., Magosin, S., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340152712719 · Cited by 354
Self-citationUrea Cycle Disorders: Diagnosis, Pathophysiology, and Therapy
Brusilow, S. W., & Maestri, N. E. (1996) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00072-0 · Cited by 353
WORLDWIDE EPIDEMIOLOGY OF HUMAN ADENOVIRUS INFECTIONS
SCHMTTZ, H., WIGAND, R., & HEINRICH, W. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113563 · Cited by 340
Kurts, C., Miller, J. F. A. P., Subramaniam, R. M., Carbone, F. R., & Heath, W. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.409 · Cited by 309
Persistence in muscle of an adenoviral vector that lacks all viral genes
Chen, H.-H., Mack, L. M., Kelly, R., Ontell, M., Kochanek, S., & Clemens, P. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1645 · Cited by 291
Replication-Defective Vector Based on a Chimpanzee Adenovirus
Farina, S. F., Gao, G.-P., Xiang, Z. Q., Rux, J. J., Burnett, R. M., Alvira, M. R., Marsh, J., Ertl, H. C. J., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11603-11613.2001 · Cited by 272
Canine Adenovirus Vectors: an Alternative for Adenovirus-Mediated Gene Transfer
Kremer, E. J., Boutin, S., Chillon, M., & Danos, O. (2000) · Journal of Virology · doi:10.1128/jvi.74.1.505-512.2000 · Cited by 245
Kafri, T., Morgan, D., Krahl, T., Sarvetnick, N., Sherman, L., & Verma, I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11377 · Cited by 244
Reid, T., Galanis, E., Abbruzzese, J., Sze, D., Andrews, J., Romel, L., Hatfield, M., Rubin, J., & Kirn, D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301512 · Cited by 243
Introduction: The role of innate immunity in the adaptive immune response
Janeway Jr., C. A., & Medzhitov, R. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0142 · Cited by 243
Croyle, M. A., Chirmule, N., Zhang, Y., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4792-4801.2001 · Cited by 229
Self-citationAdeno-associated virus vectors for gene therapy: more pros than cons?
Monahan, P. E., & Samulski, R. J. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01810-4 · Cited by 227
An Oral Vaccine Against NMDAR1 with Efficacy in Experimental Stroke and Epilepsy
During, M. J., Symes, C. W., Lawlor, P. A., Lin, J., Dunning, J., Fitzsimons, H. L., Poulsen, D., Leone, P., Xu, R., Dicker, B. L., et al. (2000) · Science · doi:10.1126/science.287.5457.1453 · Cited by 220
Snyder, R. O., Spratt, S. K., Lagarde, C., Bohl, D., Kaspar, B., Sloan, B., Cohen, L. K., & Danos, O. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.16-1891 · Cited by 211
Gene Transfer by Adeno-Associated Virus Vectors into the Central Nervous System
Xiao, X., Li, J., McCown, T. J., & Samulski, R. J. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6396 · Cited by 202
Molnar-Kimber, K. L., Sterman, D. H., Chang, M., Kang, E. H., ElBash, M., Lanuti, M., Elshami, A., Gelfand, K., Wilson, J. M., Kaiser, L. R., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.14-2121 · Cited by 200
Chirmule, N., Xiao, W., Truneh, A., Schnell, M. A., Hughes, J. V., Zoltick, P., & Wilson, J. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2420-2425.2000 · Cited by 198
Self-citationMack, C. A., Song, W.-R., Carpenter, H., Wickham, T. J., Kovesdi, I., Harvey, B.-G., Magovern, C. J., Isom, O. W., Rosengart, T., Falck-Pedersen, E., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-99 · Cited by 192
Yang, Y., Su, Q., Grewal, I. S., Schilz, R., Flavell, R. A., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6370-6377.1996 · Cited by 181
Kay, M. A., Meuse, L., Gown, A. M., Linsley, P., Hollenbaugh, D., Aruffo, A., Ochs, H. D., & Wilson, C. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4686 · Cited by 169
Croyle, M. A., Chirmule, N., Zhang, Y., & Wilson, J. M. (2002) · Human Gene Therapy · doi:10.1089/104303402760372972 · Cited by 166
Self-citationBrockstedt, D. G., Podsakoff, G. M., Fong, L., Kurtzman, G., Mueller-Ruchholtz, W., & Engleman, E. G. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4724 · Cited by 165
Cordier, L., Gao, G.-P., Hack, A. A., McNally, E. M., Wilson, J. M., Chirmule, N., & Sweeney, H. L. (2001) · Human Gene Therapy · doi:10.1089/104303401750061267 · Cited by 152
Self-citationAdenoviral Vector-Mediated Gene Transfer for Human Gene Therapy
Breyer, B., Jiang, W., Cheng, H., Zhou, L., Paul, R., Feng, T., & He, T.-C. (2001) · Current Gene Therapy · doi:10.2174/1566523013348689 · Cited by 145
Chen, Y., Yu, D., Charlton, D., & Henderson, D. (2000) · Human Gene Therapy · doi:10.1089/10430340050083289 · Cited by 143
Harvey, B.-G., Maroni, J., O'Donoghue, K. A., Chu, K. W., Muscat, J. C., Pippo, A. L., Wright, C. E., Hollmann, C., Wisnivesky, J. P., Kessler, P. D., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340152712638 · Cited by 130
Toxicity of a First-Generation Adenoviral Vector in Rhesus Macaques
Lozier, J. N., Csákó, G., Mondoro, T. H., Krizek, D. M., Metzger, M. E., Costello, R., Vostal, J. G., Rick, M. E., Donahue, R. E., & Morgan, R. A. (2002) · Human Gene Therapy · doi:10.1089/10430340152712665 · Cited by 128
Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig
Jooss, K. U., Turka, L., & Wilson, J. M. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300595 · Cited by 125
Self-citationManning, W. C., Paliard, X., Zhou, S., Pat Bland, M., Lee, A. Y., Hong, K., Walker, C. M., Escobedo, J. A., & Dwarki, V (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7960-7962.1997 · Cited by 122
Zhang, Y., Chirmule, N., Gao, G.-P., & Wilson, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8003-8010.2000 · Cited by 119
Self-citationSarukhan, A., Camugli, S., Gjata, B., von Boehmer, H., Danos, O., & Jooss, K. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.269-277.2001 · Cited by 119
Self-citationBuilding a Better Vector: The Manipulation of AAV Virions
Rabinowitz, J. E., & Samulski, R. J. (2000) · Virology · doi:10.1006/viro.2000.0707 · Cited by 117
Xiao, W., Chirmule, N., Schnell, M. A., Tazelaar, J., Hughes, J. V., & Wilson, J. M. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0045 · Cited by 114
Self-citationAdeno-associated virus site-specifically integrates into a muscle-specific DNA region
Dutheil, N., Shi, F., Dupressoir, T., & Linden, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080079397 · Cited by 92
Ponnazhagan, S., Mahendra, G., Curiel, D. T., & Shaw, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9493-9501.2001 · Cited by 88
Ge, Y., Powell, S., Van Roey, M., & McArthur, J. G. (2001) · Blood · doi:10.1182/blood.v97.12.3733 · Cited by 86
Klonjkowski, B., Gilardi-Hebenstreit, P., Hadchouel, J., Randrianarison, V., Boutin, S., Yeh, P., Perricaudet, M., & Kremer, E. J. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.17-2103 · Cited by 80
Zabner, J., Chillón, M., Grunst, T., Moninger, T. O., Davidson, B. L., Gregory, R. J., & Armentano, D. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8689-8695.1999 · Cited by 80
Young, S. M., & Samulski, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241508998 · Cited by 79
Crystal, R. G., Harvey, B., Wisnivesky, J. P., O'Donoghue, K. A., Chu, K. W., Maroni, J. M., Muscat, J. C., Pippo, A. L., Wright, C. E., Kaner, R. J., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340152712647 · Cited by 78
Preexisting Immunity to Adenovirus in Rhesus Monkeys Fails To Prevent Vector-Induced Toxicity
Varnavski, A. N., Zhang, Y., Schnell, M., Tazelaar, J., Louboutin, J.-P., Yu, Q.-C., Bagg, A., Gao, G.-P., & Wilson, J. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5711-5719.2002 · Cited by 77
Antivector and antitransgene host responses in gene therapy.
Hackett, N. R., Kaminsky, S. M., Sondhi, D., & Crystal, R. G. (2000) · PubMed · Cited by 66
Schneider, H., Mühle, C., Douar, A. M., Waddington, S. N., Jiang, Q., von der Mark, K., Coutelle, C., & Rascher, W. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.233 · Cited by 64
Bromberg, J. S., DeBruyne, L. A., & Qin, L. (1998) · Advances in immunology · doi:10.1016/s0065-2776(08)60611-2 · Cited by 58
DeMatteo, R. P., Chu, G., Ahn, M., Chang, E. O., Barker, C. F., & Markmann, J. F. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5330-5335.1997 · Cited by 55
Anand, V., Chirmule, N., Fersh, M., Maguire, A. M., & Bennett, J. (2000) · Human Gene Therapy · doi:10.1089/10430340050015914 · Cited by 54
Self-citationPrasad, S. A., Norbury, C. C., Chen, W., Bennink, J. R., & Yewdell, J. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4809 · Cited by 53
Induction of tolerance to human factor VIII in mice
Chao, H., & Walsh, C. (2001) · Blood · doi:10.1182/blood.v97.10.3311 · Cited by 51
Rahman, A., Tsai, V., Goudreau, A., Shinoda, J., Wen, S. F., Ramachandra, M., Ralston, R., Maneval, D. C., LaFace, D., & Shabram, P. W. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0316 · Cited by 50
Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer
Malik, A. K., Monahan, P. E., Allen, D. L., Chen, B.-G., Samulski, R. J., & Kurachi, K. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3555-3565.2000 · Cited by 48
Cited by
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Delivery of bioactive molecules into the cell: the Trojan horse approach
Dietz, G. P. H., & Bähr, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.005 · Cited by 469
Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9324-2 · Cited by 447
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
Israelow, B., Song, E., Mao, T., Lu, P., Meir, A., Liu, F., Alfajaro, M. M., Wei, J., Dong, H., Homer, R. J., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20201241 · Cited by 415
Barth, H., Aktories, K., Popoff, M. R., & Stiles, B. G. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.3.373-402.2004 · Cited by 399
Metadata
- Authors
- Jooss, K., & Chirmule, N.
- Venue
- Gene Therapy
- Published
- 2003-05-20
- Volume
- 10
- Issue
- 11
- Pages
- 955-963
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2052131992
- Cited by
- 277
- References
- 76
- FWCI
- 15.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.